ARTICLES
Tykerb helpful in reducing stem cells in breast cancer
LONDON A new cancer drug called Tykerb from GlaxoSmithKline may help stop breast cancer from recurring because of its ability to decrease tumor-causing breast cancer stem cells, according to published reports.Glaxo reinvents old drugs in effort to save sales
LONDON As a result of a struggling market, GlaxoSmithKline has turned its attention toward reinventing old drugs to treat different ailments, rather than making new drugs, according to published reports.GlaxoSmithKline forms an alliance with Regulus for microRNA research
BOSTON GlaxoSmithKline and Regulus Therapeutics LLC announced an alliance to develop and market microRNA-targeted therapeutics, according to published reports.Lilly cuts 500 jobs in Indianapolis location
INDIANAPOLIS In an attempt to cut costs, Eli Lilly and Co.Cancer drug able to put melanoma in remission
WASHINGTON Researchers from the Dana Farber Cancer Institute in Boston have revealed that the cancer drug Gleevec, used to treat metastatic melanoma, was able to force the cancer into remission for the first time.Analysis shows pain reduction for fibromyalgia patients using Lyrica
CHICAGO A pooled analysis presented at the annual Academy of Neurology meeting reports that Pfizer’s Lyrica reduced pain in patients with fibromyalgia, whether or not they experienced symptoms of anxiety or depression.
Load More
Loading Post Please Wait...